BEGIN:VCALENDAR VERSION:2.0 PRODID:-//wp-events-plugin.com//7.2.3.1//EN TZID:America/Detroit X-WR-TIMEZONE:America/Detroit BEGIN:VEVENT UID:57@clevelandvets.org DTSTART;TZID=America/Detroit:20221109T130000 DTEND;TZID=America/Detroit:20221109T170000 DTSTAMP:20221025T211831Z URL:https://www.clevelandvets.org/events/cardiology-update-canine-valvular -disease-and-feline-cardiomyopathies/ SUMMARY:Cardiology Update: Canine Valvular Disease and Feline Cardiomyopath ies DESCRIPTION:This meeting will be held at the Watershed Stewardship Center i n West Creek Reservation in Parma\, OH. This meeting is sponsored by Puri na.\n\nMyxomatous Valve Disease in Dogs\, Part 1 – Staging &\; Precli nical Disease: Myxomatous (degenerative) valvular disease is the most imp ortant cause of heart disease and cardiac failure in dogs. This session fo cuses on clinical recognition\, practical approaches to staging\, and whe n to start treatment.\n\nObjectives/Outcomes for participants:\n1. Offer a n overview of the clinical\, imaging\, and laboratory diagnosis and stagin g of acquired (myxomatous\, degenerative) valvular heart disease in the d og.\n2. Outline the ACVIM staging of myxomatous valvular heart disease in the dog.\n3. Explain the diagnostic imaging findings (radiography\, echoca rdiography) typical of mild to advanced myxomatous valve disease of the d og.\n4. Describe the value and challenges of using blood natriuretic pepti de (NT-proBNP) concentrations in the assessment of myxomatous valve disea se of the dog.\n5. Summarize the preclinical therapy of myxomatous valve d isease of the dog and the criteria that justify starting treatment before the onset of clinical signs.\n\nMyxomatous Valve Disease in Dogs\, Part 2 – Management Approaches: This (continuation) session focuses on the th erapy of myxomatous valvular disease in dogs\, emphasizing the appropriate use of cardiac drugs and the management of heart failure.\n\nObjectives/ Outcomes for participants:\n1. List the three major classes of drugs used in the management of heart disease and heart failure in dogs with myxomat ous valve disease\n2. List the direct vasodilator drugs sometimes used in the treatment of myxomatous valve disease and their relative indications\ n3. Outline an approach for treating acute left-sided heart failure in the dog.\n4. Outline an approach for treating and monitoring the canine patie nt with chronic congestive heart failure\; indicate the level of evidence supporting each treatment.\n5. Discuss potential treatments for complicat ions and comorbidities associated with chronic valvular disease\, includi ng airway diseases\, arrhythmias\, pulmonary hypertension\, and chronic ki dney disease.\n\nFeline Cardiomyopathy Part 1 – Diagnosis of Feline Card iomyopathies: This session details the relevant pathology\, causes\, and clinical outcomes of feline myocardial diseases. Diagnostic tests used for recognition and staging of cardiomyopathies are reviewed. A diagnostic a pproach to the assessment of asymptomatic feline heart murmurs is emphasi zed. Finally\, the practical use of cardiac biomarkers and critical aspect s of clinical examination and diagnostic imaging are discussed.\n\n\nObje ctives/Outcomes for participants:\n\n1. Draw a picture of the left ventric le in the main types of feline cardiomyopathy and indicate the\nfundamenta l functional problems with each form.\n2. List the differential diagnosis of systolic heart murmurs in cats and rank these based on likelihood in k ittens (cats 7 years of age.\n3. Describe the clinical use of ELISA-based and reference laboratory tests for NT-proBNP in cats with a heart murmur or signs of respiratory distress.\n4. Conduct a diagnostic workup for card iac murmurs in cats.\n5. Discuss an overview of the benefits and limitatio ns of echocardiography and thoracic radiography for assessing cats with p reclinical cardiomyopathy and those with heart failure.\n\nFeline Cardiomy opathies\, Part 2 – Outcomes & Management: This session considers outcom es\, prognosis\, and different approaches to managing feline cardiomyopat hies. Cats with asymptomatic hypertrophic cardiomyopathy\, acute and chro nic congestive heart failure\, and arterial thromboembolism in cats are c onsidered. Case vignettes are used to emphasize clinical relevancy.\n\nObj ectives/Outcomes for participants:\n1. Discuss the relevant issues related to managing asymptomatic feline hypertrophic cardiomyopathy.\n2. Outline an approach for recognizing and managing acute congestive heart failure (C HF) in cats with cardiomyopathy.\n3. Outline an approach for the chronic management (treatment and follow-up) of congestive heart failure (CHF) in cats with cardiomyopathy.\n4. List the clinical signs of arterial thrombo embolism and the related clinical laboratory findings.\n5. Discuss the pre vention and potential treatments for arterial thromboembolism associated w ith feline cardiomyopathies.\n\nJohn Bonagura graduated from the Ohio Sta te University\, was a rotating intern at the Animal Medical Center in New York\, and completed residencies and specialty board certifications in C ardiology and Internal Medicine at Ohio State. For most of his career\, Jo hn was Head of Cardiology & Interventional Medicine at Ohio State\, where he achieved the rank of tenured Professor and is currently Professor Eme ritus. Dr. Bonagura was visiting research fellow at Edinburgh University\ , Scotland\, and completed a five-year term as the Gilbreath-McLorn Endowe d Professor of Veterinary Cardiology at the University of Missouri before  rejoining the faculty at Ohio State in 2001. John moved to the North Car olina State University College of Veterinary Medicine in 2019\, where he is currently affiliated.\n\nJohn served a three-year term as President of the ACVIM specialty of Cardiology and is a member of the Board. He is the long-time Editor of Kirk's Current Veterinary Therapy and co-author of a  Colour Atlas of Veterinary Cardiology and the recently published Ware: C ardiovascular Diseases in Companion Animals. He currently serves on the ed itorial Board of the Journal of Veterinary Cardiology and the American So ciety of Echocardiography CASE. In addition\, Dr. Bonagura has written or co-authored over 300 scientific publications and book chapters. He is the recipient of multiple college awards for teaching in the professional and graduate programs at Ohio State\, andthe OSU campus Award for Distinguish ed Teaching. Additional honors include the Bourgelat award of the British Small Animal Veterinary Association\, Doctor Honoris Causa from the Univ ersity of Barcelona\, Kirk Lifetime Achievement Award from the American Co llege of Veterinary Internal Medicine\, Faculty Achievement Award of the American Association of Veterinary Clinicians\, and distinguished Alumnus awards from The Ohio State University College of Veterinary Medicine and the Animal Medical Center. LOCATION:WATERSHED STEWARDSHIP CENTER\, 2277 West Ridgewood Drive\, Parma\, OH\, 44134\, United States X-APPLE-STRUCTURED-LOCATION;VALUE=URI;X-ADDRESS=2277 West Ridgewood Drive\, Parma\, OH\, 44134\, United States;X-APPLE-RADIUS=100;X-TITLE=WATERSHED S TEWARDSHIP CENTER:geo:0,0 END:VEVENT BEGIN:VTIMEZONE TZID:America/Detroit X-LIC-LOCATION:America/Detroit BEGIN:STANDARD DTSTART:20221106T010000 TZOFFSETFROM:-0400 TZOFFSETTO:-0500 TZNAME:EST END:STANDARD END:VTIMEZONE END:VCALENDAR